Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

fospropofol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND HX0969w is a novel water-soluble prodrug designed to release propofol and gamma-hydroxybutyrate (GHB) and has a… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2011
2011
BackgroundFospropofol disodium is a water-soluble prodrug of propofol. A subset analysis was undertaken of elderly patients (≥65… Expand
2010
2010
STUDY OBJECTIVE To evaluate the safety of intravenous (IV) fospropofol when used to provide minimal to moderate sedation in… Expand
2009
2009
Fospropofol, a phosphorylated prodrug version of the popular induction agent propofol, is hydrolyzed in vivo to release active… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
2009
2009
1. Sichrovsky TC, Mittal S, Steinberg JS. Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 2008;106… Expand
Review
2008
Review
2008
Propofol (2,6-diisopropylphenol) is inadequably soluble in water and is therefore formulated as a lipid emulsion. This may have… Expand
2008
2008
Sedation plays a central role in making colonoscopy tolerable for patients and feasible for the endoscopist to perform. The array… Expand
  • figure 1
  • figure 2
2008
2008
Using pharmacokinetic and pharmacodynamic data published in the scientific literature, we have developed interactive on-line… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
Following i.v. administration, fospropofol is rapidly metabolized by alkaline phosphatase enzymes, releasing propofolFP. Several… Expand
Review
2006
Review
2006
  • T. Gan
  • Clinical pharmacokinetics
  • 2006
  • Corpus ID: 19952165
The ability to deliver safe and effective moderate sedation is crucial to the ability to perform invasive procedures. Sedative… Expand